Metastatic NSCLC - Non-Small Cell Lung Cancer Clinical Trials

10 clinical trials for Metastatic NSCLC - Non-Small Cell Lung Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) — RECRUITING · PHASE2
• Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% — RECRUITING · PHASE2
• Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations. — RECRUITING · PHASE2
• Large Granular Lymphocytes in mNSCLC Treated With Nivolumab — RECRUITING
• ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) — NOT_YET_RECRUITING · PHASE2
• XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC — NOT_YET_RECRUITING · PHASE2
• Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01) — ACTIVE_NOT_RECRUITING
• Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) — NOT_YET_RECRUITING · PHASE2

Refine this search